Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients--monoinstitutional experience

World Journal of Surgery
L StaibHans Günther Beger

Abstract

The objective of this study was to determine surgical morbidity and long-term outcome of colorectal cancer surgery for quality control reasons and as the basis for new treatment modalities. Surgically treated colorectal cancer patients (mean age 65 years) were followed prospectively in a university center (110 months mean follow-up, 1978-1999). Overall survival (OAS), radicality, extent of resection, recurrence, and morbidity were analyzed (log-rank test of survival, multivariate analysis). Altogether, 2452 colorectal cancers localized in the colon (CC, 44.6%), rectum (RC, 44.8%) or multicentric (CRC, 10.6%) were of UICC stages I (19%), II (30%), III (21%), IV (20%), or undetermined (10%). Radicality and stage but not tumor localization influenced the OAS (p <0.0001). The 5-year/10-year OASs were 50%/42% (all), 78%/66% (R0), 46%/36% (R1), 4%/0% (R2), 0% (unresected) and 86%/79% (I), 70%/58% (II), 42%/33% (III), 3%/0% (IV) or 21%/12% (undetermined), respectively (p <0.0001). Multivisceral resections (17%) resulted in morbidity and survival rates equal to those for standard resection. The overall tumor recurrence rate was 27%, mainly with both local and distant relapse (15%). Surgery-related complications occurred in 18% (all), 1...Continue Reading

Citations

Apr 23, 2004·International Journal of Colorectal Disease·Adriano TocchiElia Bettelli
Mar 2, 2006·International Journal of Colorectal Disease·Feng GaoJun-lin Liang
May 8, 2007·International Journal of Colorectal Disease·M ScharfenbergW Schwenk
Jun 22, 2010·International Journal of Colorectal Disease·Laura A HealyJohn V Reynolds
Jun 16, 2010·International Journal of Colorectal Disease·Sigmar StelznerHelmut Witzigmann
Aug 11, 2010·International Journal of Colorectal Disease·Andreas VolkHans Detlev Saeger
Dec 17, 2009·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·J-Matthias von der SchulenburgWillemien Schurer
Oct 19, 2006·Journal of the National Cancer Institute·Anand GovindarajanCalvin H L Law
Aug 20, 2005·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·T N NickelsenO Kronborg
Aug 4, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·O H SjoA Nesbakken
Nov 20, 2008·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·W HohenbergerS Merkel
Aug 25, 2007·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·R BendardafS Pyrhönen
Aug 19, 2009·Annals of Surgical Oncology·Christoph ReissfelderJürgen Weitz
Mar 14, 2009·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Darko ZdravkovićBorislav Tosković
Mar 20, 2014·British Journal of Cancer·T S HveemH E Danielsen
Nov 15, 2011·International Journal of Colorectal Disease·Paul M VerheijenApollo Pronk
May 25, 2012·World Journal of Surgical Oncology·Leif SchiffmannErnst Klar
Dec 7, 2007·World Journal of Surgery·Hassan SaidiDavid Karuri
Feb 13, 2010·World Journal of Surgery·Yik-Hong HoRussel Stitz
Jul 11, 2013·World Journal of Surgery·Torsten UeberrueckAnnelore Altendorf-Hofmann
Oct 31, 2012·Clinical Colorectal Cancer·Marko KornmannUNKNOWN Study Group Oncology of Gastrointestinal Tumors (FOGT)
Dec 8, 2009·Cirugía española·José Errasti AlustizaNaiara Parraza Díez
Apr 4, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S H YunH K Chun
Jun 19, 2007·Annales Françaises D'anesthèsie Et De Rèanimation·S MératB Baranger
Jan 11, 2005·Lancet·Jürgen WeitzMarkus W Büchler
Mar 24, 2005·Annales de chirurgie·J M ProskeW Schwenk
May 16, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C GielenA Hoofwijk
Jul 29, 2015·Annals of Surgical Oncology·Derek J ErstadJames C Cusack
Nov 7, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Ramesh OmranipourFarinaz Safavi
Sep 23, 2014·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·U ClauerJ Roder
Jun 9, 2016·Clinical Colorectal Cancer·Johannes LemkeMarko Kornmann
Dec 12, 2012·Digestive Diseases·J O Larkin, P R O'Connell
Mar 2, 2017·The Libyan Journal of Medicine·Riyad BendardafSeppo Pyrhönen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Surgical Oncology
Pedro Luna-PérezSonia Labastida
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen
F MaruschH Lippert
Cancer Chemotherapy and Pharmacology
J F ClearyG Wilding
Clinica Chimica Acta; International Journal of Clinical Chemistry
Yeon-Joo KimTae Hyun Kim
© 2022 Meta ULC. All rights reserved